SEC Form 4 · accession 0001246360-17-001204
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey H Burbank
Officer — Chief Executive Officer · Director
Period of report
Mar 3, 2017
Accepted (ET)
Mar 6, 2017 · 6:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 3, 2017 | M | 28,022 | $0.00 | A | 964,271 | D | |
| Common Stock | Mar 3, 2017 | F | 13,185 | $28.31 | D | 951,086 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Unit | $0.00 | Mar 3, 2017 | M | 28,022 | D | Mar 3, 2015 | Mar 3, 2017 | Common Stock | 28,022 | 0 | D |